With cancer cases continuing to place pressure on healthcare systems worldwide, the demand for dependable, cost-effective, and quality-assured oncology medicines is steadily increasing. Like many countries in Eastern Europe, Georgia is strengthening its healthcare infrastructure to improve access to modern cancer treatments while maintaining cost efficiency. To achieve this objective, many pharmaceutical importers, hospitals, distributors,